Mubasher TV
Contact Us Advertising   العربية

Nahdi Medical Co. Announces its Interim Financial Results for the Period Ending on 2025-09-30 ( Nine Months )

NAHDI 4164 -9.78% 116.20 -12.60
Element List Current Quarter Similar quarter for previous year %Change Previous Quarter % Change
Sales/Revenue 2,461.5 2,353.3 4.597 2,527.6 -2.615
Gross Profit (Loss) 940.6 845.4 11.26 966 -2.629
Operational Profit (Loss) 187.6 175.8 6.712 260.6 -28.012
Net profit (Loss) 161.2 182.2 -11.525 238.4 -32.382
Total Comprehensive Income 165.5 156.2 5.953 239.4 -30.868
All figures are in (Millions) Saudi Arabia, Riyals


Element List Current Period Similar period for previous year %Change
Sales/Revenue 7,624 7,083.4 7.631
Gross Profit (Loss) 2,850.3 2,637 8.088
Operational Profit (Loss) 718.2 680.9 5.478
Net profit (Loss) 654.8 662.9 -1.221
Total Comprehensive Income 657.9 661.3 -0.514
Total Shareholders Equity (after Deducting Minority Equity) 2,516 2,409.1 4.437
Profit (Loss) per Share 5.04 5.1
All figures are in (Millions) Saudi Arabia, Riyals


Element List Amount Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value - -
All figures are in (Millions) Saudi Arabia, Riyals


Element List Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is Revenue: In the third quarter of 2025, Nahdi Medical Company’s revenue continued its growth momentum delivering 4.6% increase or SAR 108.2 million reaching SAR 2,461.5 million compared to SAR 2,353.3 million in the same quarter last year. This performance was driven by robust results across all business segments (please refer to the attached press release for detailed analysis).
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is Net Profit: The Company reported a net profit of SAR 161.2 million for the third quarter of 2025, compared to SAR 182.2 million in the same quarter last year, representing a decrease of SAR 20.9 million. It is worth mentioning that net profit grew by SAR 11.8 million or 8.0%, after excluding the impact of a one-time zakat provision releases recorded in Q3 2024 of SAR 32.7 million.

The key factors contributing to this performance are as follows:

- Gross Profit: Gross profit increased by 11.3% or SAR 95.2 million to reach SAR 940.6 million, compared to SAR 845.4 million in the same quarter last year. Gross margin improved by 2.3% reaching 38.2% from 35.9% in the same quarter last year, supported by a favorable shift in product mix within the retail business.

-Operating Profit: Operating profit recorded a solid increase of 6.7% or SAR 11.7 million reaching SAR 187.6 million, compared to SAR 175.8 million in the same quarter last year. This increase was mainly driven by higher gross profit, supported by the increased revenue and a favorable product mix. The improvement in gross profit was partially offset by higher operating expenses, reflecting the Company’s strategic investments in new pharmacy openings while continuing to invest in the expansion of its Healthcare and UAE businesses, and ongoing digital transformation initiatives.

Additionally, there was an increase of SAR 4.6 million in the items below operating profit mainly related to higher interest in lease liabilities incurred to support the accelerated business expansions. The difference in zakat is mainly due to a one-time zakat provision release of SAR 32.7 million recorded in the same quarter last year.

As result of the above factors, the company recorded SAR 161.2 million in net profit.

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is Revenue: The Company recorded a total revenue of SAR 2,461.5 in the third quarter of 2025 representing a 2.6% decline compared to the previous quarter which included Hajj seasonality.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is Net Profit: The Company reported a net profit of SAR 161.2 million for the third quarter of 2025. This represents a decrease of 32.4% or SAR 77.2 million compared to the previous quarter, mainly due to the Company’s planned phasing pattern of the operating expenses.
The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is Revenue: Nahdi continued its sales performance momentum, delivering 7.6% growth during the nine months of the year compared to the same period last year. Total revenue increased by SAR 540.6 million reaching SAR 7,624.0 million up from SAR 7,083.4 million for the same period last year, driven by a solid performance in the Retail business, in addition to robust contributions from the Healthcare business, which grew by 79.4% and the UAE business which increased by 39.4%.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is Net Profit: The Company recorded a net profit of SAR 654.8 million representing 8.6% of revenue in the current period of 2025, compared to SAR 662.9 million for the same period last year, slightly lower by SAR 8.1 million.

The key factors contributing to this performance are as follows:

- Gross Profit: Gross profit increased by 8.1% or SAR 213.4 million to reach SAR 2,850.3 million, compared to SAR 2,637.0 million in the same period last year. Gross margin rose by 20 bps reaching 37.4% compared to 37.2% in the same period last year.

- Operating Profit: Operating profit increased by 5.5% or SAR 37.3 million, reaching SAR 718.2 million compared to SAR 680.9 million in the same period last year. This strong performance was achieved despite the Company’s continued investments to support future growth, including opening new pharmacies, expanding its Healthcare and UAE businesses and advancing digital initiatives. These investments resulted in higher operating expenses; however, this was partially offset by operational efficiencies and strong revenue growth, which supported the increase in operating profit.

Items below operating profit recorded a net increase of SAR 45.4 million, primarily due to higher interest in lease liabilities, to support the accelerated business expansions.

As result of the above factors, the Company recorded SAR 654.8 million in net profit.

Statement of the type of external auditor's report Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) N/A
Reclassification of Comparison Items Certain comparative information has been reclassified to align with the current presentation for the period ending 30 Sep 2025.
Additional Information -Total Comprehensive Income decreased as a result of normal business activities which impacted on the actuarial estimate for the end-of-service indemnity.

-In accordance with the Company’s governance, it strictly adheres to Shariah principles in all areas of its business, including banking and investment activities. As a result, all costs incurred, and revenues generated from these activities are Shariah-compliant.

Attached Documents   

Comments